Table 1.
Baseline descriptive and clinical characteristics of each cohort
| Measurement | Lifestyle | Pharmacotherapy | Metabolic and Bariatric Surgery |
|---|---|---|---|
| (N=53) | (N=40) | (N=78) | |
| Mean Follow-up Duration (baseline to last visit, days) | 144 (102.1) | 138 (61.4) | 370 (47.1) |
| Age (Years) | 15.2 (1.06) | 14.5 (1.88) | 17.3 (1.67) |
| Sex (n [%] Male) | 26 (49.1%) | 13 (32.5%) | 25 (32.1%) |
| BMI (kg/m2) | 39.2 (5.95) | 40.2 (5.99) | 55.8 (11.0) |
| Percent of 95th BMI Percentile | 143 (23.6) | 149 (20.6) | 195 (41.1)6 |
| Total Cholesterol (mg/dL) | 153 (30.4)8 | 154 (22.1) | 167 (32.5)65 |
| Triglycerides (mg/dL) | 141 (72.1)8 | 124 (82.8) | 105 (39.4)65 |
| HDL-Cholesterol (mg/dL) | 39.9 (7.44)8 | 38.6 (7.23) | 40.0 (8.59)65 |
| Non-HDL-Cholesterol (mg/dL) | 113 (30.0)8 | 115 (22.3) | 101 (49.9)65 |
| LDL-Cholesterol (mg/dL) | 84.9 (22.3)8 | 91.6 (18.2)1 | 108 (29.1)65 |
| Fasting Glucose (mg/dL) | 93.3 (7.73)11 | 79.7 (9.71) | 83.0 (14.6)65 |
| Fasting Insulin (U/L) | 31.8 (37.1)12 | 25.0 (17.0)1 | 22.3 (11.2)65 |
| HOMA-IR | 7.47 (9.05)12 | 5.02 (3.6)1 | 4.78 (2.87)65 |
| Systolic BP (mmHg) | 127 (14.7)8 | 122 (11.5) | 125 (13.0)3 |
| Diastolic BP (mmHg) | 73.8 (8.55)8 | 67.9 (9.66) | 73.5 (9.71)3 |
Values expressed are mean (SD) or N (%) where indicated.
Superscripts represent number of observations missing.